Strategic Decisions Group Elects New Partner to Lead Life Sciences Practice in North America

0


WILLIAM LEAF-HERRMANN

Decision makers in the life sciences industry are constantly on the lookout for new ways to create value … SDG is at the forefront of developing and applying new approaches to guide them in their journey. tradeoffs in terms of value, risk, investment and time.

Management consulting firm Strategic Decisions Group (SDG) has announced that William Leaf-Herrmann has joined the firm as a partner. Dr. Leaf-Herrmann has assumed leadership of SDG’s life science practice in North America.

Dr. Leaf-Herrmann has over 25 years of experience structuring and developing corporate, therapeutic, product and portfolio strategies for clients in the pharmaceutical and biotechnology industries. Dr. Leaf-Herrmann, who began his consulting career at SDG in 1993, returns to the firm after several years as a senior director at IQVIA, a provider of advanced assays, technological solutions and clinical research services for the life science industry.

“We are delighted that our longtime friend and colleague William is returning to SDG as a partner in our global life sciences practice,” said Dr Mark Seidler, CEO of SDG. “William has extensive experience in decision science and aligning with optimal strategies for the life science industry. ”

Dr Leaf-Herrmann’s clients included many leading companies in the industry, including seven of the world’s top 10 pharmaceutical companies, three of the largest Japanese pharmaceutical companies, and medical device, diagnostics and generics companies.

At SDG, Dr. Leaf-Herrmann is responsible for the firm’s growth in the practice of life sciences in North America.

“William brings in-depth experience that spans the business, therapeutics, products, portfolio and R&D strategy,” said Deepak Veeraraghavan, who leads the global life sciences practice from the company’s office at Düsseldorf, Germany. “Its expertise in decision and life sciences will strengthen and extend the services SDG provides to decision makers in the pharmaceutical, biotechnology and medical device industries, particularly in North America. “

“Decision makers in the life sciences industry are constantly looking for new ways to create value and better understand technical risks and business uncertainties,” said Dr. Leaf-Herrmann. “SDG is at the forefront of developing and applying new approaches to guide them in their trade-offs in terms of value, risk, investment and time. These solutions can help clients improve R&D productivity, better understand the business potential of licenses and acquisitions, and design better development strategies to meet the diverse and evolving needs of patients, payers and providers. health care.

Dr. Leaf-Herrmann’s experience spans a wide range of interdisciplinary projects, including supporting clients with business valuation, portfolio strategy, therapeutic area strategy, and business strategy. He has designed and implemented portfolio management processes for the R&D portfolios of global pharmaceutical companies. He is experienced in the application of decision science and in the structuring and evaluation of complex strategic alternatives.

Prior to joining SDG, Dr Leaf-Herrmann was Senior Director at IQVIA, a global company resulting from the merger of Quintiles and IMS Health. Dr Leaf-Herrmann previously served as a senior director at IMS Health and vice chairman of Analysis Group, an economics consulting firm.

Dr Leaf-Herrmann holds a PhD in Physics from Harvard University and a BS in Physics and Applied Mathematics from Purdue University. He is based in Brookline, Mass., Outside of Boston.

About the Strategic Decisions Group

Founded in 1981, Strategic Decisions Group is a strategy consulting firm renowned for its expertise in strategic decision-making, risk management, stakeholder alignment and value creation. Through a collaborative team-based approach, SDG helps clients find innovative and creative strategies to thrive today, while helping them develop internal skills and more effective decision-making processes to overcome challenges. competitive in the future. A unique combination of analytical skills, strategy development techniques and industry experience makes SDG a preferred strategy consultant for the Fortune 500 Global Rankings. For more information, visit http: // www. sdg.com. In 2021, the firm celebrates its 40th anniversary.

Share the article on social media or by email:


Share.

Comments are closed.